LAMEDITECH Statistics
Total Valuation
LAMEDITECH has a market cap or net worth of KRW 65.52 billion. The enterprise value is 57.93 billion.
Market Cap | 65.52B |
Enterprise Value | 57.93B |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
LAMEDITECH has 8.77 million shares outstanding. The number of shares has increased by 44.66% in one year.
Current Share Class | 8.77M |
Shares Outstanding | 8.77M |
Shares Change (YoY) | +44.66% |
Shares Change (QoQ) | +0.12% |
Owned by Insiders (%) | 29.44% |
Owned by Institutions (%) | 0.00% |
Float | 4.79M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 8.71 |
PB Ratio | 3.92 |
P/TBV Ratio | 4.00 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -5.46 |
EV / Sales | 7.70 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -3.94 |
Financial Position
The company has a current ratio of 9.65, with a Debt / Equity ratio of 0.05.
Current Ratio | 9.65 |
Quick Ratio | 6.73 |
Debt / Equity | 0.05 |
Debt / EBITDA | n/a |
Debt / FCF | -0.06 |
Interest Coverage | -213.94 |
Financial Efficiency
Return on equity (ROE) is -89.52% and return on invested capital (ROIC) is -52.11%.
Return on Equity (ROE) | -89.52% |
Return on Assets (ROA) | -43.57% |
Return on Invested Capital (ROIC) | -52.11% |
Return on Capital Employed (ROCE) | -56.40% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.48 |
Inventory Turnover | 1.81 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.46% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -41.46% |
50-Day Moving Average | 8,009.40 |
200-Day Moving Average | 8,798.75 |
Relative Strength Index (RSI) | 44.47 |
Average Volume (20 Days) | 44,519 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LAMEDITECH had revenue of KRW 7.52 billion and -10.61 billion in losses. Loss per share was -1,263.80.
Revenue | 7.52B |
Gross Profit | 2.83B |
Operating Income | -10.82B |
Pretax Income | -10.61B |
Net Income | -10.61B |
EBITDA | -10.32B |
EBIT | -10.82B |
Loss Per Share | -1,263.80 |
Balance Sheet
The company has 8.41 billion in cash and 818.39 million in debt, giving a net cash position of 7.59 billion or 865.65 per share.
Cash & Cash Equivalents | 8.41B |
Total Debt | 818.39M |
Net Cash | 7.59B |
Net Cash Per Share | 865.65 |
Equity (Book Value) | 16.73B |
Book Value Per Share | 1,907.93 |
Working Capital | 12.34B |
Cash Flow
In the last 12 months, operating cash flow was -10.87 billion and capital expenditures -3.84 billion, giving a free cash flow of -14.71 billion.
Operating Cash Flow | -10.87B |
Capital Expenditures | -3.84B |
Free Cash Flow | -14.71B |
FCF Per Share | -1,677.17 |
Margins
Gross margin is 37.62%, with operating and profit margins of -143.78% and -141.06%.
Gross Margin | 37.62% |
Operating Margin | -143.78% |
Pretax Margin | -141.06% |
Profit Margin | -141.06% |
EBITDA Margin | -137.15% |
EBIT Margin | -143.78% |
FCF Margin | n/a |
Dividends & Yields
LAMEDITECH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -44.66% |
Shareholder Yield | n/a |
Earnings Yield | -16.20% |
FCF Yield | -22.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
LAMEDITECH has an Altman Z-Score of 11.74 and a Piotroski F-Score of 3.
Altman Z-Score | 11.74 |
Piotroski F-Score | 3 |